- Home
- VCEL vs SRPT Comparison
VCEL vs SRPT Comparison
Compare VCEL & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- SRPT
- Stock Information
- Founded
- VCEL 1989
- SRPT 1980
- Country
- VCEL United States
- SRPT United States
- Employees
- VCEL N/A
- SRPT N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- VCEL Health Care
- SRPT Health Care
- Exchange
- VCEL Nasdaq
- SRPT Nasdaq
- Market Cap
- VCEL 2.1B
- SRPT 2.0B
- IPO Year
- VCEL 1997
- SRPT 1997
- Fundamental
- Price
- VCEL $30.45
- SRPT $17.58
- Analyst Decision
- VCEL Strong Buy
- SRPT Hold
- Analyst Count
- VCEL 6
- SRPT 31
- Target Price
- VCEL $61.50
- SRPT $40.61
- AVG Volume (30 Days)
- VCEL 729.6K
- SRPT 7.8M
- Earning Date
- VCEL 11-06-2025
- SRPT 11-05-2025
- Dividend Yield
- VCEL N/A
- SRPT N/A
- EPS Growth
- VCEL 2045.40
- SRPT N/A
- EPS
- VCEL 0.13
- SRPT N/A
- Revenue
- VCEL $249,119,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- VCEL $18.35
- SRPT $10.78
- Revenue Next Year
- VCEL $22.47
- SRPT N/A
- P/E Ratio
- VCEL $243.20
- SRPT N/A
- Revenue Growth
- VCEL 16.13
- SRPT 64.89
- 52 Week Low
- VCEL $30.26
- SRPT $10.42
- 52 Week High
- VCEL $63.00
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- VCEL 50.41
- SRPT 45.39
- Support Level
- VCEL $30.26
- SRPT $16.85
- Resistance Level
- VCEL $33.92
- SRPT $18.84
- Average True Range (ATR)
- VCEL 1.42
- SRPT 0.96
- MACD
- VCEL -1.92
- SRPT -0.06
- Stochastic Oscillator
- VCEL 83.62
- SRPT 26.13
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.